Article date: February 1987
By: PG Newrick, D Bainton, in Volume 23, Issue 2, pages 195-198
We report on the pattern of use of benoxaprofen (Opren) in a single group practice for a period which included the complete clinical life of the drug. One hundred and seventy‐two patients of the 6495 practice patients had been prescribed benoxaprofen, but 55% had only a small exposure (less than 20 g). Recorded adverse reactions, of which none was serious, appeared in 25 patients. Most were taking benoxaprofen for osteoarthritis (53%) or non‐specific musculoskeletal pain (39.9%). The issue of a prescription was not recorded in 19.6% of cases and 88% were on additional drugs. Greater precision in record‐keeping is required to avoid problems similar to the experience with benoxaprofen.
DOI: 10.1111/j.1365-2125.1987.tb03029.x
View this article